Continuum Advisory, LLC Bridge Bio Pharma, Inc. Transaction History
Continuum Advisory, LLC
- $660 Million
- Q1 2024
A detailed history of Continuum Advisory, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 34 shares of BBIO stock, worth $875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$875% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
285Shares Held
170MCall Options Held
7.41MPut Options Held
2.61M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$800 Million40.56% of portfolio
-
Viking Global Investors LP25.1MShares$647 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$341 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$270 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$156 Million64.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.82B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...